PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-50.30%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-42.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-107.57%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-114.45%
Negative operating income growth while 5715.T is at 10.21%. Joel Greenblatt would press for urgent turnaround measures.
-158.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-158.05%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-158.05%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.07%
Negative 10Y revenue/share CAGR while 5715.T stands at 22.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-85.07%
Negative 5Y CAGR while 5715.T stands at 22.43%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
29.49%
Positive 3Y CAGR while 5715.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
100.00%
Positive long-term OCF/share growth while 5715.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
Positive OCF/share growth while 5715.T is negative. John Neff might see a comparative advantage in operational cash viability.
100.00%
Positive 3Y OCF/share CAGR while 5715.T is negative. John Neff might see a big short-term edge in operational efficiency.
96.50%
Below 50% of 5715.T's 255.77%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
96.50%
Below 50% of 5715.T's 255.77%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
78.40%
Below 50% of 5715.T's 163.90%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
150.03%
3Y equity/share CAGR above 1.5x 5715.T's 7.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.83%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
71.44%
Inventory growth well above 5715.T's 4.55%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
20.47%
Positive asset growth while 5715.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.65%
We have a declining book value while 5715.T shows 2.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
67.11%
Debt growth far above 5715.T's 1.34%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
No Data
No Data available this quarter, please select a different quarter.